Literature DB >> 10218963

Extracellular matrix-associated bone morphogenetic proteins are essential for differentiation of murine osteoblastic cells in vitro.

M Suzawa1, Y Takeuchi, S Fukumoto, S Kato, N Ueno, K Miyazono, T Matsumoto, T Fujita.   

Abstract

Osteoblastic differentiation is an essential part of bone formation that compensates resorbed bone matrix to maintain its structural integrity. Cells in an osteoblast lineage develop differentiated phenotypes during a long-term culture in vitro. However, intrinsic mechanisms whereby these cells differentiate into mature osteoblasts are yet unclear. Bone morphogenetic proteins (BMPs) stimulate osteoblastic differentiation and bone formation. We demonstrate that mouse osteoblastic MC3T3-E 1 cells constitutively expressed messenger RNAs (mRNAs) for BMP-2 and BMP-4 and accumulated BMPs in collagen-rich extracellular matrices. BMPs associated with the extracellular matrices were involved in the induction of osteoblastic differentiation of nonosteogenic mesenchymal cells as well as cells in the osteoblast lineage. MC3T3-E1 cells constitutively expressed type IA and type II BMP receptors. When a kinase-deficient type IA BMP receptor was stably transfected to MC3T3-E 1 cells to obliterate BMP-2/4 signaling, these cells not only failed to respond to exogenous BMP-2 but lost their capability of differentiation into osteoblasts that form mineralized nodules. These observations strongly suggest that endogenous BMP-2/4 accumulated in extracellular matrices are essential for the osteoblastic differentiation of cells in the osteoblast lineage. Therefore, the regulatory mechanism of BMP-2/4 actions in osteoblastic cells is a principal issue to be elucidated for better understanding of pathogenesis of bone losing diseases such as osteoporosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10218963     DOI: 10.1210/endo.140.5.6704

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  36 in total

1.  Osteocyte control of bone formation via sclerostin, a novel BMP antagonist.

Authors:  David G Winkler; May Kung Sutherland; James C Geoghegan; Changpu Yu; Trenton Hayes; John E Skonier; Diana Shpektor; Mechtild Jonas; Brian R Kovacevich; Karen Staehling-Hampton; Mark Appleby; Mary E Brunkow; John A Latham
Journal:  EMBO J       Date:  2003-12-01       Impact factor: 11.598

2.  Prospects and limitations of the rational engineering of fibrillar collagens.

Authors:  Ireneusz Majsterek; Erin McAdams; Eijiro Adachi; Shirish T Dhume; Andrzej Fertala
Journal:  Protein Sci       Date:  2003-09       Impact factor: 6.725

3.  Bioreactor strategy in bone tissue engineering: pre-culture and osteogenic differentiation under two flow configurations.

Authors:  Junho Kim; Teng Ma
Journal:  Tissue Eng Part A       Date:  2012-07-19       Impact factor: 3.845

4.  Bone morphogenetic protein-2 and -6 heterodimer illustrates the nature of ligand-receptor assembly.

Authors:  Michael J Isaacs; Yasuhiko Kawakami; George P Allendorph; Byung-Hak Yoon; Juan Carlos Izpisua Belmonte; Senyon Choe
Journal:  Mol Endocrinol       Date:  2010-05-19

5.  Tenofovir treatment of primary osteoblasts alters gene expression profiles: implications for bone mineral density loss.

Authors:  Iwen F Grigsby; Lan Pham; Louis M Mansky; Raj Gopalakrishnan; Ann E Carlson; Kim C Mansky
Journal:  Biochem Biophys Res Commun       Date:  2010-02-18       Impact factor: 3.575

6.  Chrysin promotes osteogenic differentiation via ERK/MAPK activation.

Authors:  Wenfeng Zeng; Yan Yan; Fayun Zhang; Chunling Zhang; Wei Liang
Journal:  Protein Cell       Date:  2013-06-06       Impact factor: 14.870

7.  Depolarization alters phenotype, maintains plasticity of predifferentiated mesenchymal stem cells.

Authors:  Sarah Sundelacruz; Michael Levin; David L Kaplan
Journal:  Tissue Eng Part A       Date:  2013-06-05       Impact factor: 3.845

8.  Development of stepwise osteogenesis-mimicking matrices for the regulation of mesenchymal stem cell functions.

Authors:  Takashi Hoshiba; Naoki Kawazoe; Tetsuya Tateishi; Guoping Chen
Journal:  J Biol Chem       Date:  2009-09-17       Impact factor: 5.157

9.  Effect of targeted delivery of bone morphogenetic protein-2 on bone formation in type 1 diabetes.

Authors:  Ronaldo Barcellos de Santana; Phillip C Trackman
Journal:  Int J Oral Maxillofac Implants       Date:  2015 May-Jun       Impact factor: 2.804

10.  Tgf-Beta inhibition restores terminal osteoblast differentiation to suppress myeloma growth.

Authors:  Kyoko Takeuchi; Masahiro Abe; Masahiro Hiasa; Asuka Oda; Hiroe Amou; Shinsuke Kido; Takeshi Harada; Osamu Tanaka; Hirokazu Miki; Shingen Nakamura; Ayako Nakano; Kumiko Kagawa; Kenichiro Yata; Shuji Ozaki; Toshio Matsumoto
Journal:  PLoS One       Date:  2010-03-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.